Form 8-K - Current report:
SEC Accession No. 0001640334-25-001318
Filing Date
2025-07-25
Accepted
2025-07-25 16:05:48
Documents
15
Period of Report
2025-07-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K yubo_8k.htm   iXBRL 8-K 32779
2 SECURITIES PURCHASE AGREEMENT yubo_ex101.htm EX-10.1 134908
  Complete submission text file 0001640334-25-001318.txt   316179

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA yubo-20250723.xsd EX-101.SCH 5022
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE yubo-20250723_lab.xml EX-101.LAB 14189
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE yubo-20250723_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE yubo-20250723_pre.xml EX-101.PRE 8943
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE yubo-20250723_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT yubo_8k_htm.xml XML 3819
Mailing Address ROOM 105, BUILDING 5, 31 XISHIKU AVENUE BEIJING F4 00000
Business Address ROOM 105, BUILDING 5, 31 XISHIKU AVENUE BEIJING F4 00000 86 (010) 6615-5141
Yubo International Biotech Ltd (Filer) CIK: 0000895464 (see all company filings)

EIN.: 113074326 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21320 | Film No.: 251151726
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)